Stockreport

BeOne Medicines (ONC) Reports $1.5B Revenue for Q4, $1.1B from Lymphoma Treatment [Yahoo! Finance]

GRAIL, Inc.  (GRAL) 
PDF BeOne Medicines AG (NASDAQ: ONC ) is among the 12 best stocks to buy and hold for the next 2 years On February 26, BeOne Medicines AG (NASDAQ:ONC) reported total glob [Read more]